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Abstract: 
 
Context: Compression socks have become increasingly popular with athletes due to perceived 
enhancement of exercise performance and recovery. However, research examining the efficacy 
of compression socks to reduce exercise-associated muscle damage has been equivocal, with few 
direct measurements of markers of muscle damage. Objective: To examine the influence of 
compression socks worn during a marathon on creatine kinase (CK) levels. Design: A 
randomized controlled trial. Setting: 2013 Hartford Marathon, Hartford, CT. Participants: 
Adults (n = 20) randomized to control (CONTROL; n = 10) or compression sock (SOCK; n = 10) 
groups. Main Outcome Measures: Blood samples were collected 24 hours before, immediately 
after, and 24 hours following the marathon for the analysis of CK, a marker of muscle damage. 
Results: Baseline CK levels did not differ between CONTROL (89.3 [41.2] U/L) and SOCK 
(100.0 [56.2] U/L) (P = .63). Immediately following the marathon (≤1 h), CK increased 273% 
from baseline (P < .001 for time), with no difference in exercise-induced changes in CK from 
baseline between CONTROL (+293.9 [278.2] U/L) and SOCK (+233.1 [225.3] U/L; P = .60 for 
time × group). The day following the marathon (≤24 h), CK further increased 1094% from 
baseline (P < .001 for time), with no difference in changes in CK from baseline between 
CONTROL (+ 1191.9 [1194.8] U/L) and SOCK (+889.1 [760.2] U/L; P = .53 for time × group). 
These similar trends persisted despite controlling for potential covariates such as age, body mass 
index, and race finishing time (Ps > .29). Conclusions: Compression socks worn during a 
marathon do not appear to mitigate objectively measured markers of muscle damage 
immediately following and 24 hours after a marathon. 
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Article: 
 
The benefits of regular sustained aerobic exercise are indisputable; however, extreme endurance 
events, such as a marathon foot race (42.2 km), can be associated with marked muscle damage, 
inflammation, and injury.1–3 Compression socks have become increasingly popular to wear 
during and/or after marathons due to an athlete’s perceived enhancement of performance and/or 
recovery. Such purported improvements are largely fueled by a manufacturer’s claims that 
compression socks reduce microtrauma, enhance venous return, reduce swelling space, and/or 
accelerate clearance of exercise metabolites.4,5 
 
However, studies examining the efficacy of compression socks to reduce muscle damage during 
exercise and/or in the recovery period have been equivocal.6–10 This is in part due to the 
difficulty of conducting placebo-controlled trials and the use of subjective, qualitative reporting 
as primary outcome measures.7 Further complicating this, studies measuring objective 
physiological markers of muscle damage have been vastly heterogenous in terms of (1) the type 
of compression garment used (eg, whole body, sleeves, knee high socks) and/or (2) the modality 
of exercise being tested.7 Only one randomized controlled trial exists that has sought to examine 
the influence of compression socks worn during a marathon on muscle damage.11 This is 
surprising given that marathon participation has increased 40% over the past decade.12 Given the 
increasing use of compression socks for athletes participating in long course endurance events 
such as a marathon,13 establishing their efficacy for use is an important and valuable 
investigation. 
 
Consequently, this investigation sought to examine the influence of wearing compression socks 
during a marathon run on creatine kinase (CK; a marker of muscle damage) levels, before, 
immediately after, and the day following a marathon, among recreational athletes running the 
2013 Hartford Marathon (Hartford, CT). We hypothesized that CK levels would increase 
immediately and 24 hours after competing in the Hartford Marathon, and the increase in 
marathon-induced CK levels would be lower in athletes who ran the marathon with compression 
socks compared with controls. 
 
Procedures 
 
Participants 
 
Runners (10 men and 10 women) were recruited through an e-mail sent to all participants 
registered for the 2013 Hartford Marathon. Subjects were nonsmokers between 20 and 51 years 
of age; free of known cardiovascular, metabolic, and/or coagulatory disease; free of known acute 
or chronic injuries; and had not previously used compression socks. Female subjects were 
premenopausal and did not take any form of hormone-based contraceptives. In addition, subjects 
agreed to refrain from taking medications or supplements 24 hours before, during, or after the 
marathon, such as aspirin or nonsteroidal anti-inflammatory drugs. All subjects provided written, 
informed consent to participate as approved by the Hartford Hospital Institutional Review Board 
(Protocol #ZALE004311HU) in agreement with the guidelines set forth by the Declaration of 
Helsinki. 
 
Study Design 
 
Subjects reported to the marathon exposition the day before the marathon (October 11, 2013) for 
assessment of pre-exercise (PRE) measures. Following assessment of height and weight and the 
calculation of body mass index, resting blood pressure and heart rate (Welch Allyn, Inc, 52000 
Vital Signs Monitor; Skaneateles Falls, NY) were measured. Subjects provided a detailed 
medical and exercise history, which included training volume leading up to the marathon. 
Venous blood was obtained to measure CK and hematocrit (Hct). Blood was also obtained 
immediately after completion of the marathon (FINISH) in the main medical tent approximately 
100 m from the finish line and within 24 hours of the race finish (POST) at Hartford Hospital. 
 
Using www.randomization.com, subjects were randomly assigned to one of 20 parallel groups 
(1:1 replication seed #2278) by the study coordinator (ALZ) to the compression sock (SOCK; 5 
men and 5 women) or the control (CONTROL; 5 men and 5 women) group upon initial 
screening. A product donation from 2XU (2XU North America LLC, Carlsbad, CA) ensured that 
all subjects in SOCK wore foot-to-knee, graded compression socks with the same pressure grade 
(Compression Performance Run Sock; 19–25 mm Hg at the ankle; 2XU LLC). Subjects in 
SOCK were sized according to self-reported calf circumference and shoe size and received their 
socks at the marathon exposition the day before the marathon. Subjects in SOCK were instructed 
to wear their socks to the race start and throughout the duration of the marathon and FINISH 
blood draw, but refrain from wearing compression socks between FINISH and POST blood 
draw. Subjects in CONTROL were instructed to wear their typical socks, but refrain from 
compression sock usage during training, the marathon, or the day after the marathon. 
 
Assessment of Physical Activity 
 
All subjects completed a physical activity recall for the 24-hour periods before and after the 
marathon using question #8 from the Paffenbarger Physical Activity Questionnaire14 to compare 
physical activity levels between groups so that any potential differences in the CK response to 
exercise could be attributable to the influence of the intervention (ie, compression socks) and not 
differences in physical activity. Subjects categorized their physical activity by hours spent in 
sedentary behaviors; light-, moderate-, and vigorous-intensity physical activity; and sleep. 
 
Blood Sample Collection 
 
Following a period of 5-minute seated rest, whole blood (25 mL) was collected from an 
antecubital vein without stasis by single venipuncture, centrifuged (2000×g, 10 min), and 
aliquoted into cryogenic vials to be archived within 4 hours at −80°C for future analysis. 
 
Blood Sample Analyses 
 
Whole blood was delivered to Clinical Laboratory Partners at Hartford Hospital (Hartford, CT) 
at the end of each study day for analysis of Hct to be used for the estimation of plasma volume 
changes over the course of the marathon. CK activity was measured in duplicate via kinetic assay 
(Sekisui Diagnostics, Charlottetown, Canada) with absorbance measured spectrophotometrically 
(Versa Max Microplate Reader; Molecular Devices, Sunnyvale, CA) at a wavelength of 340 nm 
every 30 seconds. The intra-assay coefficient of variation was 4.1%. CK was corrected for the 
estimated exercise-induced changes in plasma volume, according to the formula of van 
Beaumont.15 
 
Statistical Analyses 
 
The sample size was determined using data from our previous findings in Boston Marathon 
participants,16 which showed a ∼300% increase in CK immediately following the marathon in 
CONTROL. Our calculations indicated that 10 subjects in each group would reject the null 
hypothesis with 87% power (P ≤ .05). Data (presented as mean [SD]) were analyzed by SPSS 
(version 24.0; IBM Inc, Chicago, IL). Differences in baseline characteristics between groups 
were assessed with a one-way analysis of variance. 
 
Creatine kinase was logarithmically transformed before analysis to normalize distribution. To 
determine the effects of compression socks on changes in CK, we used a linear mixed model for 
1-wayrepeated measures analysis of variance (RMANOVA), incorporating time as the within-
subjects factor and group (CONTROL vs SOCK) as the between-subjects factor. Potential 
categorical factors (eg, sex) that could affect the relationship among the main effects and 
outcomes were investigated within the model. Continuous variables (eg, age, training mileage, 
and finishing time) were investigated using analysis of covariance. 
 
Characteristics such as age, sex, body mass index, distance run the week before the race, and 
finishing time were not significant factors in the repeated measures model for CK. Training 
mileage was entered and evaluated in the final RMANOVA as a covariate. The RMANOVA 
model was also used to assess group differences in physical activity before and after the 
marathon. An alpha level of P ≤ .05 was considered statistically significant. 
 
Table 1. Mean Physical and Performance Characteristics (SD) of the SOCK (n = 10) Versus 
CONTROL (n = 10) Subjects 
Variable CONTROL (n = 10) SOCK (n = 10) 
Age, y 35.5 (8.0) 36.9 (8.4) 
Body weight, lb 152.0 (27.3) 159.4 (34.0) 
Body mass index, kg/m2 23.0 (2.1) 23.9 (4.3) 
SBP, mm Hg 134.3 (21.3) 139.2 (17.8) 
DBP, mm Hg 73.3 (11.6) 79.7 (10.6) 
HR, bpm 63.5 (14.9) 67.0 (10.4) 
Training mileage, miles/wk 26.3 (0.2) 38.6 (12.2)* 
Official finishing time, h:min:s 4:20:42 (0:38:33) 4:02:33 (0:38:29) 
Abbreviations: DBP, diastolic blood pressure; HR, heart rate; SBP, systolic blood pressure. Note: Training 
mileage = average miles run per week during training for the Hartford Marathon. 
*P < .05; CONTROL versus SOCK. 
 
Results 
 
Subject Characteristics 
 
Baseline characteristics were similar between groups (Table 1), with the exception that athletes 
in SOCK trained on average ∼12 miles more per week than CONTROL (P < .05). It is important 
to note that 2 outliers (CONTROL, n = 1; SOCK, n = 1) deviated >2 SD of the mean and removal 
of these 2 outliers results in no statistical difference in weekly running volume between those 
wearing compression socks (34.8 [9.5] miles) versus control (28.6 [7.4] miles; P = .16). 
However, a data management decision was made to report on these data given the small sample 
size. There were no differences in groups in terms of reported “marathon running years” among 
those wearing compression socks (3.7 [2.5] y) versus control (4.2 [6.1]; P = .60). 
 
Race Day Characteristics 
 
Race day weather was optimal with an average temperature of 54°F (high 62°F, low 46°F), no 
precipitation, low humidity, and partly cloudy. 
 
Physical Activity 
 
There were no group differences in hours spent in vigorous-, moderate-, and light-intensity 
physical activity, as well as sitting or sleeping time (Ps > .05) at PRE or POST; however, both 
groups spent less time in light-intensity exercise (P < .02) and more time sleeping at POST 
relative to PRE (P < .03). There were no correlations between marathon-induced increases in CK 
and hours spent in vigorous-, moderate-, or light-intensity physical activity, sitting, or sleeping 
time at POST (Ps > .23). 
 
Marker of Muscle Damage 
 
Baseline CK levels did not differ between CONTROL (89.3 [41.2] U/L) and SOCK (100.0 
[56.2] U/L) (P = .63), and were within normal reference ranges for males and females (Figure 1). 
Immediately following the marathon (≤1 h; FINISH), CK increased 273% from baseline 
(P < .001 for time), with no difference in exercise-induced changes in CK from baseline between 
CONTROL (Δ = +293.9 [278.2] U/L) and SOCK (Δ = +233.1 [225.3] U/L; P = .60 for 
time × group). The day following the marathon (≤24 h; POST), CK further increased 1094% 
from baseline (P < .001 for time), with no difference in changes in CK from baseline between 
CONTROL (Δ = +1191.9 [1194.8] U/L) and SOCK (Δ = +889.1 [760.2] U/L; P = .53 for 
time × group). These similar trends between CONTROL and SOCK persisted despite controlling 
for potential covariates such as age, sex, body mass index, and race finishing time (Ps > .29). 
 
 
Figure 1. Group mean (SD) of creatine kinase activity (CK) before (PRE), immediately after 
(FINISH), and the day after the marathon (POST). CK data were log transformed for analysis. 
 
Five of the marathoners (CONTROL, n = 2; SOCK, n = 3) had CK levels that met the clinical 
definition of a marked CK elevation (CK > 10 times the upper limit of normal) 24 hours after the 
marathon (ie, FINISH); however, chi-square analysis indicated no significant difference between 
groups (χ2 = 0.267; P = .50). 
 
Plasma Volume Changes 
 
Hematocrit decreased from FINISH to POST (CONTROL: 43.1% [4.1%] vs 41.0% [3.0%] and 
SOCK: 41.7% [2.5%] vs 40.7% [2.8%]; Ps < .01), suggestive of an increase in plasma volume 
from immediate postexercise to the following day. There were no group differences in changes 
in Hct (P = .57), and adjustment CK for Hct to account for changes in plasma volume15 did not 
change the nature of the results. 
 
Discussion 
 
This study sought to examine the influence of compression socks worn during a marathon foot 
race on exercise-induced muscle damage in endurance athletes. Compression socks worn during 
a marathon did not appear to mitigate a well-established marker of muscle damage (ie, CK) at 
any individual time point (ie, FINISH, POST) compared with the control condition. 
 
To the best of our knowledge, one randomized controlled trial exists that sought to examine the 
influence of compression socks on exercise-induced muscle damage among marathon runners. 
Areces et al11 examined serum CK concentrations before and immediately after a marathon 
among 34 experienced runners randomly assigned to wear foot-to-knee graduated compression 
socks (n = 17) or conventional socks (n = 17) during a marathon. Similar to the present study, the 
authors found no differences in marathon-induced increases in CK from baseline between SOCK 
(215.5 [131.0] U/L to 487.0 [227.0] U/L) and CONTROL (164.1 [64.9] U/L to 390.4 
[166.1] U/L; P = .16). The present study confirms the findings of Areces et al11 that compression 
socks worn during a marathon do not appear to attenuate the expected rise in CK immediately 
following a marathon. The present study further adds to the literature by being the first to report 
on CK changes 24 hours following a marathon; a critical time point to assess muscle damage. 
Exercise-induced increases in CK follow a biphasic response, reaching peak concentrations ∼24 
hours and ∼4 days following an acute bout of exercise.17–20 Indeed, the day following the 
marathon (≤24 h; POST), CK concentrations further increased 1094% from baseline (P < .001), 
but with no difference in CK elevations from baseline between CONTROL and SOCK (P = .53). 
 
Hypothetical mechanisms underlying performance and recovery benefits of compression socks 
differ depending on their timing of use (ie, during or after exercise), but are similar in that their 
mechanisms of action target components of Virchow’s triad.21Compression socks during 
exercise are thought to reduce microtrauma and enhance venous return by applying an external, 
circumferential pressure gradient that reduces swelling space, improves blood flow, and in turn 
improves performance.4,5Compression socks worn during recovery are thought to accelerate 
metabolic waste clearance, attenuate edema and swelling, and improve oxygen delivery to the 
muscle.22,23 A recent meta-analysis incorporating 12 studies indicates a favorable effect of 
compression socks to enhance recovery from muscle damage based on CK and reduced severity 
of delayed onset muscle soreness.7 However, of the studies included in the meta-analysis, not 
one sought to examine the influence of compression socks in response to a sustained, aerobic 
event (ie, marathon), making the interpretation of the findings difficult to apply to endurance 
athletes. A separate systematic review concluded that the available literature does not fully 
support or refute the use of compression socks for performance or recovery.24 Of the trials 
included, 3 studies found no difference in running performance while wearing compression 
socks,8,10,11 while one demonstrated improvements in running speed and performance.25 To the 
best of our knowledge, only one randomized controlled trial exists that examined recovery 
in marathon runners and found that compression socks worn for 48 hours after a marathon 
improved functional recovery (ie, time to exhaustion on a treadmill 2 wk after a marathon) by 
5.9%.26 However, it is difficult to compare these data to the present study as we did not 
originally seek to examine the influence of compression socks on recovery, per se. Rather, we 
sought to isolate the influence of compression socks worn during competition only; a critical 
time point of exposure to perturbations in which the actual muscle damage occurs and originates 
from (ie, the marathon). The use of compression socks after the marathon would add a 
confounding factor and limit the applicability of our findings. 
 
Limitations 
 
We caution that our interpretations are based on a small investigation and larger studies are 
required to confirm these findings. Furthermore, we did not perform a comprehensive analysis of 
markers of muscle damage and inflammation due to financial restraints. There are myriad other 
factors that may have been influenced by the use of compression socks that are unrelated to the 
CK response to exercise such as lymph flow, muscle oscillation, microtrauma, inflammation, and 
blood clotting factors.7,27 Compression pressure exerted by the garments on the skin was not 
directly measured. Rather, subjects in the SOCK wore graded compression socks (19–
25 mm Hg) based on self-reported calf circumference. This method of sizing most closely 
recapitulates how athletes will use these garments and enhances the translational value of our 
findings to recreational marathon runners in general. We did not measure subjective ratings of 
perceived pain. Compression socks cannot truly be placebo controlled; therefore, it is always 
possible that compression socks may result in psychological advantages that translate into 
performance gains as compression socks are anecdotally well tolerated. Finally, the 
generalizability of our results may be limited to recreational, but not elite or competitive runners. 
It is well documented that running intensity is positively correlated to the magnitude of CK 
elevations following endurance exercise. Indeed, previous data from our laboratory have 
demonstrated a greater CK response following a marathon in runners with a finishing time of <4 
hours than runners who finish ≥4 hours.16 Compression socks may prove to be more efficacious 
in other runner cohorts known to have a greater CK response to a marathon such as athletes with 
a finishing time <4 hours, men, statin users, or any level runner competing in a race with more 
eccentric muscle demands (ie, a net downhill race such as the Boston Marathon).16 
 
Practical Applications 
 
Compression socks are regularly touted as an inexpensive countermeasure to mitigate exercise-
associated muscle damage. The present study does not support a role for compression socks 
worn during a marathon to buffer the expected rise of CK during or after a marathon event in 
recreational runners. However, it is possible that compression socks may positively 
influence other markers or parameters associated with exhaustive exercise that have yet to be 
measured or known. Should recreational marathoners choose to wear compression during a 
marathon, our results are reassuring in that they do not show a negative impact of compression 
socks on muscle damage following prolonged, strenuous endurance exercise. This is important 
given previous reports in the literature of compression garments causing undue constriction and 
pain.9 To avoid these potential adverse consequences, socks should be sized according to calf 
circumference (vs shoe size) to avoid excessive pressure at the calf, which may be further 
exacerbated by compartment swelling during a marathon.28 By following these specifications, 
athletes may be reassured that compression socks likely do not cause or exacerbate injury, which 
is critically important given the time and effort associated with training, performance, and 
recovery. 
 
Conclusions 
 
Compression socks are commonly marketed to recreational runners as an effective 
countermeasure to mitigate exercise-associated muscle damage. However, the present study does 
not support a role for compression socks worn during a marathon to buffer the expected rise of 
CK immediately following or 24 hours after a marathon event. Nevertheless, the present study 
did not reveal any adverse consequences of compression socks on muscle damage. It remains 
possible that compression socks may beneficially alter other physiological parameters not 
assessed in the present study and/or provide psychological advantages that translate into 
improvements in marathon performance in some, but not all individuals. 
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